Implementing a Medicines at Transitions Intervention (MaTI) for patients with heart failure: a process evaluation of the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
09 Oct 2024
Historique:
received: 16 02 2023
accepted: 23 08 2024
medline: 10 10 2024
pubmed: 10 10 2024
entrez: 9 10 2024
Statut: epublish

Résumé

Heart failure is a major global health challenge incurring a high rate of mortality, morbidity and hospitalisation. Effective medicines management at the time of hospital discharge into the community could reduce poor outcomes for people with heart failure. Within the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) programme, the Medicines at Transitions Intervention (MaTI) was co-designed to improve such transitions, with a cluster randomised controlled trial to test effectiveness. The MaTI includes a patient toolkit and transfer of discharge medicines information to community pharmacy. This paper aims to determine the degree to which the intervention was delivered, and identify barriers and facilitators experienced by staff for the successful implementation of the intervention. The study was conducted in six purposively selected intervention sites. A mixed-methods design was employed using hospital staff interviews, structured and unstructured ward observations, and routine trial data about adherence to the MaTI. A parallel mixed analysis was applied. Qualitative data were analysed thematically using the Framework method. Data were synthesised, triangulated and mapped to the Consolidated Framework for Implementation Research (CFIR). With limited routines of communication between ward staff and community pharmacy, hospital staff found implementing community pharmacy-related steps of the intervention challenging. Staff time was depleted by attempts to bridge system barriers, sometimes leading to steps not being delivered. Whilst the introduction of the patient toolkit was often completed and valued as important patient education and a helpful way to explain medicines, the medicines discharge log within it was not, as this was seen as a duplication of existing systems. Within the CFIR the most applicable constructs were identified as 'intervention complexity' and 'cosmopolitanism' based on how well hospitals were networked with community pharmacies, and the availability of hospital resources to facilitate this. The MaTI was generally successfully implemented, particularly the introduction of the toolkit. However, implementation involving community pharmacy was more challenging and more effective communication systems are needed to support wider implementation. 11/04/2018 ISRCTN66212970. https://www.isrctn.com/ISRCTN66212970 .

Sections du résumé

BACKGROUND BACKGROUND
Heart failure is a major global health challenge incurring a high rate of mortality, morbidity and hospitalisation. Effective medicines management at the time of hospital discharge into the community could reduce poor outcomes for people with heart failure. Within the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) programme, the Medicines at Transitions Intervention (MaTI) was co-designed to improve such transitions, with a cluster randomised controlled trial to test effectiveness. The MaTI includes a patient toolkit and transfer of discharge medicines information to community pharmacy. This paper aims to determine the degree to which the intervention was delivered, and identify barriers and facilitators experienced by staff for the successful implementation of the intervention.
METHODS METHODS
The study was conducted in six purposively selected intervention sites. A mixed-methods design was employed using hospital staff interviews, structured and unstructured ward observations, and routine trial data about adherence to the MaTI. A parallel mixed analysis was applied. Qualitative data were analysed thematically using the Framework method. Data were synthesised, triangulated and mapped to the Consolidated Framework for Implementation Research (CFIR).
RESULTS RESULTS
With limited routines of communication between ward staff and community pharmacy, hospital staff found implementing community pharmacy-related steps of the intervention challenging. Staff time was depleted by attempts to bridge system barriers, sometimes leading to steps not being delivered. Whilst the introduction of the patient toolkit was often completed and valued as important patient education and a helpful way to explain medicines, the medicines discharge log within it was not, as this was seen as a duplication of existing systems. Within the CFIR the most applicable constructs were identified as 'intervention complexity' and 'cosmopolitanism' based on how well hospitals were networked with community pharmacies, and the availability of hospital resources to facilitate this.
CONCLUSION CONCLUSIONS
The MaTI was generally successfully implemented, particularly the introduction of the toolkit. However, implementation involving community pharmacy was more challenging and more effective communication systems are needed to support wider implementation.
TRIAL REGISTRATION BACKGROUND
11/04/2018 ISRCTN66212970. https://www.isrctn.com/ISRCTN66212970 .

Identifiants

pubmed: 39385160
doi: 10.1186/s12913-024-11487-x
pii: 10.1186/s12913-024-11487-x
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1210

Subventions

Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009
Organisme : National Institute for Health Research (NIHR) (Programme Grants for Applied Research)
ID : RP-PG-0514-20009

Investigateurs

Gerry Armitage (G)
Alison Blenkinsopp (A)
Robert Turner (R)
Andrew Taylor (A)
Ian Kellar (I)
Suzanne Hartley (S)
Chris Bojke (C)
John Wright (J)

Informations de copyright

© 2024. The Author(s).

Références

Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572–80. https://doi.org/10.1016/S0140-6736(17)32520-5 .
doi: 10.1016/S0140-6736(17)32520-5 pubmed: 29174292 pmcid: 5814791
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200. https://doi.org/10.1093/eurheartj/ehw128 .
doi: 10.1093/eurheartj/ehw128 pubmed: 27206819
McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail. 2012;14(8):803–69.
doi: 10.1093/eurjhf/hfs105 pubmed: 22828712
Simms AD, Baxter PD, Cattle BA, et al. An assessment of composite measures of hospital performance and associated mortality for patients with acute myocardial infarction. Analysis of individual hospital performance and outcome for the National Institute for Cardiovascular Outcomes Research (NICOR). Eur Heart Journal: Acute Cardiovasc Care. 2013;2(1):9–18.
Ruppar TM, Cooper PS, Mehr DR, et al. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J Am Heart Association. 2016;5(6):e002606.
doi: 10.1161/JAHA.115.002606
Department of Health and Social Care. The pharmaceutical services (advanced and enhanced services)(England) directions. The National Health Services Act 2006: Department of Health and Social Care. 2013. p. 4–13.
Fylan B, Ismail H, Hartley S, et al. A non-randomised feasibility study of an intervention to optimise medicines at transitions of care for patients with heart failure. Pilot Feasibility Stud. 2021;7(1):1–10.
doi: 10.1186/s40814-021-00819-x
Moreau LA, Holloway I, Fylan B, et al. Using routine healthcare data to evaluate the impact of the Medicines at transitions intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the improving the safety and Continuity of Medicines management at transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilot. BMJ open. 2022;12(4):e054274.
doi: 10.1136/bmjopen-2021-054274 pubmed: 35487708 pmcid: 9058770
Damschroder L, Aron D, Keith R, SR K, Alexander J, Lowery J. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
doi: 10.1186/1748-5908-4-50 pubmed: 19664226 pmcid: 2736161
Powell C, Ismail H, Davis M, et al. Experiences of patients with heart failure with medicines at transition intervention: findings from the process evaluation of the improving the Safety and Continuity of Medicines management at transitions of care (ISCOMAT) programme. Health Expect. 2022;25(5):2503–14.
doi: 10.1111/hex.13570 pubmed: 35909321 pmcid: 9615069
Powell C, Breen L, Fylan B, et al. Improving the safety and Continuity of Medicines management at transitions of care (ISCOMAT): protocol for a process evaluation of a cluster randomised control trial. BMJ open. 2020;10(11):e040493.
doi: 10.1136/bmjopen-2020-040493 pubmed: 33234644 pmcid: 7689064
National Institute for Health Research. Restart framework: National Institute for Health Research. 2020 [Available from:  https://www.nihr.ac.uk/documents/restart-framework/24886 . accessed 25/02/22 2022.
Powell C, Ismail H, Cleverley R, et al. Patients as qualitative data analysts: developing a method for a process evaluation of the ‘Improving the safety and Continuity of Medicines management at care transitions’(ISCOMAT) cluster randomised control trial. Health Expect. 2021;24(4):1254–62.
doi: 10.1111/hex.13257 pmcid: 8369106
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.
doi: 10.1093/intqhc/mzm042 pubmed: 17872937
Pinnacle Systems Management Ltd - Supporting Community Pharmacy and Partners. Choose PharmOutcomes
Ritchie J, Lewis J, Nicholls CM, et al. Qualitative research practice: a guide for social science students and researchers. Sage; 2013.
Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117. https://doi.org/10.1186/1471-2288-13-117 .
doi: 10.1186/1471-2288-13-117 pubmed: 24047204 pmcid: 3848812
Quinn RE, Cameron K. Organizational life cycles and shifting criteria of effectiveness: some preliminary evidence. Manage Sci. 1983;29(1):33–51.
doi: 10.1287/mnsc.29.1.33
Quinn RE, Rohrbaugh J. A spatial model of effectiveness criteria: towards a competing values approach to organizational analysis. Manage Sci. 1983;29(3):363–77.
doi: 10.1287/mnsc.29.3.363
NVivo. version 12. Doncaster, Australia: QSR International.
CFIR Research Team-Center for Clinical Management Research. Consolidated Framework for Implementation Research North Campus Research Complex, 2800 Plymouth Rd, Bldg 16, Ann Arbor, MI 48109: CFIR Research Team-Center for Clinical Management Research. 2021 [Available from:  https://cfirguide.org/2021 .
Creswell JW, Clark VLP. Designing and conducting mixed methods research. Sage; 2017.
Michie S, Van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42.
doi: 10.1186/1748-5908-6-42 pubmed: 21513547 pmcid: 3096582
Fylan B, Marques I, Ismail H, et al. Gaps, traps, bridges and props: a mixed-methods study of resilience in the medicines management system for patients with heart failure at hospital discharge. BMJ Open. 2019;9(2):e023440. https://doi.org/10.1136/bmjopen-2018-023440 .
doi: 10.1136/bmjopen-2018-023440 pubmed: 30782879 pmcid: 6377507
Rojas-Ocaña MJ, Teresa-Morales C, Ramos-Pichardo JD, et al. Barriers and Facilitators of Communication in the Medication Reconciliation Process during Hospital Discharge: Primary Healthcare Professionals’ Perspectives. Healthc (Basel). 2023;11(10). https://doi.org/10.3390/healthcare11101495 . [published Online First: 2023/05/27].
Tomlinson J, Silcock J, Smith H, et al. Post-discharge medicines management: the experiences, perceptions and roles of older people and their family carers. Health Expect. 2020;23(6):1603–13.
doi: 10.1111/hex.13145 pubmed: 33063445 pmcid: 7752204
Fournier R, Kachachi S, Mouchoux C, et al. From medication reconciliation to shared medication review: Pilot study integrating support for community pharmacists within a pharmaceutical care pathway. Annales pharmaceutiques francaises. 2022;80(6):950–60. https://doi.org/10.1016/j.pharma.2022.02.008 .
doi: 10.1016/j.pharma.2022.02.008 pubmed: 35231398

Auteurs

Catherine Powell (C)

School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK. c.powell2@bradford.ac.uk.
Wolfson Centre for Applied Health Research, Bradford, UK. c.powell2@bradford.ac.uk.

Hanif Ismail (H)

Research and Innovation Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Liz Breen (L)

School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.
Wolfson Centre for Applied Health Research, Bradford, UK.
NIHR Yorkshire and Humber Patient Safety Translational Research Centre, Bradford Institute for Health Research, Bradford, UK.

Beth Fylan (B)

School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.
Wolfson Centre for Applied Health Research, Bradford, UK.
NIHR Yorkshire and Humber Patient Safety Translational Research Centre, Bradford Institute for Health Research, Bradford, UK.

Sarah L Alderson (SL)

Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

Chris P Gale (CP)

Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

Peter Gardner (P)

School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.
Wolfson Centre for Applied Health Research, Bradford, UK.

Jonathan Silcock (J)

School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.
Wolfson Centre for Applied Health Research, Bradford, UK.

Bonnie Cundill (B)

Clinical Trials Research Unit, Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK.

Amanda Farrin (A)

Clinical Trials Research Unit, Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK.

Ellen Mason (E)

Clinical Trials Research Unit, Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK.

Lauren Moreau (L)

Clinical Trials Research Unit, Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK.

David P Alldred (DP)

School of Healthcare, University of Leeds, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH